Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion

Meng Sun, Chengfei Liu, Nagalakshmi Nadiminty, Wei Lou, Yezi Zhu, Joy C. Yang, Christopher P. Evans, Qinghua Zhou, Allen C. Gao

The Prostate · 2011 · 73 citations · 43 references

DOIFull text

Open access

Abstract

These data demonstrate that sanguinarine is a potent Stat3 inhibitor and it could be developed as a therapeutic agent for prostate cancer with constitutive activation of Stat3.

References

43